Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States
- PMID: 27239192
- PMCID: PMC4867062
- DOI: 10.1155/2016/5795712
Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States
Abstract
Introduction. The progression of chronic liver disease to cirrhosis involves both innate and adaptive immune system dysfunction resulting in increased risk of infectious complications. Vaccinations against pneumococcus, hepatitis A virus (HAV), and hepatitis B virus (HBV) are well tolerated and effective in disease prevention and reduction in morbidity and mortality. Prior studies assessing vaccination rates in patients with cirrhosis have specific limitations and to date no study has provided a comprehensive evaluation of vaccination rates in patients with cirrhosis in the United States. Aim. This study assessed vaccination rates for pneumococcus, HAV, and HBV in patients with cirrhosis. Results. Overall 59.7% of patients with cirrhosis received at least 1 vaccination during the study period. Vaccination rates within the same or following year of cirrhosis diagnosis were 19.9%, 7.7%, and 11.0% against pneumococcus, HAV, and HBV, respectively. Trend analysis revealed significant increases in vaccination rates for pneumococcus in all patients with cirrhosis and within subgroups based on age, gender, and presence of concomitant diabetes. Conclusion. The study demonstrated that vaccination rates in patients with cirrhosis remain suboptimal. Ultimately, the use of electronic medical record (EMR) reminders improved communication between healthcare professionals and public health programs to increase awareness are fundamental to reducing morbidity, mortality, and health-care related costs of vaccine preventable diseases in patients with cirrhosis.
Figures



Similar articles
-
Quality of Care in Patients With Cirrhosis: Trends in Recommended Adult Vaccination Coverage.Mayo Clin Proc Innov Qual Outcomes. 2020 Sep 22;4(6):667-682. doi: 10.1016/j.mayocpiqo.2020.06.007. eCollection 2020 Dec. Mayo Clin Proc Innov Qual Outcomes. 2020. PMID: 33367212 Free PMC article.
-
The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.Am J Med Sci. 2007 Jan;333(1):26-34. doi: 10.1097/00000441-200701000-00004. Am J Med Sci. 2007. PMID: 17220691
-
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.Hepatology. 2011 Jan;53(1):42-52. doi: 10.1002/hep.24024. Epub 2010 Dec 13. Hepatology. 2011. PMID: 21254161
-
NIH consensus development statement on management of hepatitis B.NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29. NIH Consens State Sci Statements. 2008. PMID: 18949020
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
Cited by
-
Improving hepatitis A vaccination rates in hospitalised patients with cirrhosis: insights and lessons learnt.BMJ Open Qual. 2022 Apr;11(2):e001723. doi: 10.1136/bmjoq-2021-001723. BMJ Open Qual. 2022. PMID: 35440438 Free PMC article. No abstract available.
-
Infections in Cirrhosis.Curr Treat Options Gastroenterol. 2019 Jun;17(2):254-270. doi: 10.1007/s11938-019-00229-2. Curr Treat Options Gastroenterol. 2019. PMID: 30980335 Free PMC article. Review.
-
Quality of Care in Patients With Cirrhosis: Trends in Recommended Adult Vaccination Coverage.Mayo Clin Proc Innov Qual Outcomes. 2020 Sep 22;4(6):667-682. doi: 10.1016/j.mayocpiqo.2020.06.007. eCollection 2020 Dec. Mayo Clin Proc Innov Qual Outcomes. 2020. PMID: 33367212 Free PMC article.
-
Approaches for Selective Vaccinations in Cirrhotic Patients.Vaccines (Basel). 2023 Feb 16;11(2):460. doi: 10.3390/vaccines11020460. Vaccines (Basel). 2023. PMID: 36851337 Free PMC article. Review.
-
Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities.Vaccines (Basel). 2024 Feb 15;12(2):197. doi: 10.3390/vaccines12020197. Vaccines (Basel). 2024. PMID: 38400180 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources